171 related articles for article (PubMed ID: 36096078)
1. Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance.
Ho M; Zanwar S; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Rajkumar SV; Kumar S
Blood; 2022 Nov; 140(18):1997-2000. PubMed ID: 36096078
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal gammopathy of uncertain significance.
Alejo E; Puertas B; Mateos MV
Med Clin (Barc); 2023 Sep; 161(5):217-224. PubMed ID: 37330390
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal Gammopathy of Undetermined Significance.
Gonsalves WI; Rajkumar SV
Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
[TBL] [Abstract][Full Text] [Related]
4. [Cerebrospinal fluid proteins in 3 cases of polyneuritis complicating plasma cell dyscrasias].
Merelli E; Sola P; Galassi G; Gibertoni M; Colombo A; Shoenhuber R
Riv Neurobiol; 1984; 30(2-3):240-8. PubMed ID: 6544480
[No Abstract] [Full Text] [Related]
5. [Nephropathies in the course of plasma cell disorders].
Hanicki Z
Przegl Lek; 1995; 52(3):97-9. PubMed ID: 7644685
[No Abstract] [Full Text] [Related]
6. Monoclonal gammopathy and rheumatic diseases.
Raposo A; Peixoto D; Bogas M
Acta Reumatol Port; 2014; 39(1):12-8. PubMed ID: 24811457
[TBL] [Abstract][Full Text] [Related]
7. Metastatic breast cancer and monoclonal gammopathy of undetermined significance resembling multiple myeloma.
Muehlschlegel P; Gillmore R; Pomplun S
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37348925
[TBL] [Abstract][Full Text] [Related]
8. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
Greenberg AJ; Rajkumar SV; Vachon CM
Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
[TBL] [Abstract][Full Text] [Related]
9. Post-Transplant Monoclonal Gammopathy of Renal Significance: A Case Report.
Movilla Echeverri C; Montilla Cosano G; Rivera Garrido C; Suñer Poblet M; Suarez Benjumea A
Transplant Proc; 2023 Dec; 55(10):2301-2303. PubMed ID: 38030424
[TBL] [Abstract][Full Text] [Related]
10. Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding.
Saijpaul R; Khurana V; Verma R; Kaushik S
Indian J Pathol Microbiol; 2024; 67(1):192-194. PubMed ID: 38358220
[TBL] [Abstract][Full Text] [Related]
11. Myeloma-like Castleman disease with plasmacytosis and monoclonal gammopathy.
Hsieh CY; Hsu CM; Chang KC; Hsiao HH
Kaohsiung J Med Sci; 2022 Oct; 38(10):1022-1023. PubMed ID: 35880609
[No Abstract] [Full Text] [Related]
12. Monoclonal gammopathy of unknown significance: Implications of Indian baseline data.
Joshi K; Singh S
Natl Med J India; 2021; 34(6):376-378. PubMed ID: 35818096
[No Abstract] [Full Text] [Related]
13. Monoclonal gammopathy of undetermined significance in medical hospital admissions - a new strategy for screening?
Turesson I
Br J Haematol; 2020 Jun; 189(6):1010-1011. PubMed ID: 32072614
[No Abstract] [Full Text] [Related]
14. Hypercoagulability in multiple myeloma and its precursor state, monoclonal gammopathy of undetermined significance.
Kristinsson SY; Björkholm M; Schulman S; Landgren O
Semin Hematol; 2011 Jan; 48(1):46-54. PubMed ID: 21232658
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal gammopathy of ocular significance (MGOS) - a short survey of corneal manifestations and treatment outcomes.
Garderet L; Al Hariri M; Wasielica-Poslednik J; Munder M; Kormányos K; Pena C; Gozzetti A; Zhou X; Waszczuk-Gajda A; Rosinol L; Mikala G; Krzystanski M; Lisch W; Vesole D; Szentmáry N; Jurczyszyn A
Leuk Lymphoma; 2022 Apr; 63(4):984-990. PubMed ID: 34823428
[TBL] [Abstract][Full Text] [Related]
16. Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
Nador G; Ramasamy K; Panitsas F; Pratt G; Sadler R; Javaid MK
Rheumatology (Oxford); 2019 Jul; 58(7):1142-1153. PubMed ID: 31225884
[TBL] [Abstract][Full Text] [Related]
17. Second symptomatic COVID-19 infections in patients with an underlying monoclonal gammopathy.
Zanwar S; Ho M; Buadi FK; Ailawadhi S; Larsen J; Bergsagel L; Binder M; Chanan-Khan A; Dingli D; Dispenzieri A; Fonseca R; Gertz MA; Gonsalves W; Go RS; Hayman S; Kapoor P; Kourelis T; Lacy MQ; Leung N; Lin Y; Muchtar E; Roy V; Sher T; Warsame R; Fonder A; Hobbs M; Hwa YL; Kyle RA; Vincent Rajkumar S; Kumar S
Blood Cancer J; 2022 Nov; 12(11):160. PubMed ID: 36424376
[No Abstract] [Full Text] [Related]
18. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
19. [Monoclonal gammopathy of undetermined significance and multiple myeloma].
Schmalzing M; Tony HP; Knop S
Z Rheumatol; 2017 Oct; 76(Suppl 2):33-37. PubMed ID: 29330758
[TBL] [Abstract][Full Text] [Related]
20. Secondary monoclonal gammopathy of undetermined significance after allogeneic stem cell transplantation in multiple myeloma.
Schmitz MF; Otten HG; Franssen LE; van Dorp S; Strooisma T; Lokhorst HM; van de Donk NW
Haematologica; 2014 Dec; 99(12):1846-53. PubMed ID: 25193963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]